Priority Date: 01.08.12 (US 201261678367P)

RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

  • Application ID: EP13717721
  • Status: EXAMINATION REQUESTED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
Technology Company

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 174 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 01.08.2012 - Priority Date (US 201261678367P)
  • 06.02.2014 - Publication A1 (WO2014019718)
  • 10.06.2015 - Publication A1 (EP2879702)

IPC Classification